HUP0301089A2 - Dermális alkalmazási rendszerek aminolevulinsavhoz - Google Patents

Dermális alkalmazási rendszerek aminolevulinsavhoz

Info

Publication number
HUP0301089A2
HUP0301089A2 HU0301089A HUP0301089A HUP0301089A2 HU P0301089 A2 HUP0301089 A2 HU P0301089A2 HU 0301089 A HU0301089 A HU 0301089A HU P0301089 A HUP0301089 A HU P0301089A HU P0301089 A2 HUP0301089 A2 HU P0301089A2
Authority
HU
Hungary
Prior art keywords
dermal
laevulinic acid
amino
amino laevulinic
acid
Prior art date
Application number
HU0301089A
Other languages
English (en)
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Original Assignee
Photonamic Gmbh. & Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh. & Co. Kg. filed Critical Photonamic Gmbh. & Co. Kg.
Publication of HUP0301089A2 publication Critical patent/HUP0301089A2/hu
Publication of HUP0301089A3 publication Critical patent/HUP0301089A3/hu
Publication of HU230272B1 publication Critical patent/HU230272B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgyát aminolevulinsavhoz használható dermálisalkalmazási rendszer képezi, amiben kristályos aminolevulinsavattartalmazó öntapadó mátrixrendszert használnak. Ó
HU0301089A 2000-07-17 2001-07-13 Dermális alkalmazási rendszerek aminolevulinsavhoz HU230272B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10034673A DE10034673C1 (de) 2000-07-17 2000-07-17 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10034673.1 2000-07-17
PCT/EP2001/008131 WO2002005809A1 (de) 2000-07-17 2001-07-13 Dermales applikationssystem für aminolävulinsäure

Publications (3)

Publication Number Publication Date
HUP0301089A2 true HUP0301089A2 (hu) 2003-09-29
HUP0301089A3 HUP0301089A3 (en) 2006-07-28
HU230272B1 HU230272B1 (hu) 2015-11-30

Family

ID=7649181

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301089A HU230272B1 (hu) 2000-07-17 2001-07-13 Dermális alkalmazási rendszerek aminolevulinsavhoz

Country Status (19)

Country Link
US (1) US7951395B2 (hu)
EP (1) EP1303267B1 (hu)
JP (1) JP4469131B2 (hu)
AT (1) ATE263557T1 (hu)
AU (2) AU8198001A (hu)
CA (1) CA2416147C (hu)
CZ (1) CZ299086B6 (hu)
DE (2) DE10034673C1 (hu)
DK (1) DK1303267T3 (hu)
ES (1) ES2215924T3 (hu)
HU (1) HU230272B1 (hu)
NO (1) NO330303B1 (hu)
NZ (1) NZ523798A (hu)
PL (1) PL221283B1 (hu)
PT (1) PT1303267E (hu)
RU (1) RU2262930C2 (hu)
TR (1) TR200400865T4 (hu)
WO (1) WO2002005809A1 (hu)
ZA (1) ZA200210267B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
TW200616589A (en) * 2004-10-08 2006-06-01 Noven Pharma Transdermal delivery of drugs based on crystal size
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
EP3606410B1 (en) 2017-04-04 2022-11-02 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US11131796B2 (en) 2018-09-10 2021-09-28 Texas Instruments Incorporated Optical display with spatial light modulator

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (hu) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
CA2144327C (en) 1992-09-21 2002-08-06 Anna M. Richter Transcutaneous in vivo activation of photosensitive agents in blood
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
AU3176695A (en) * 1994-09-20 1996-04-04 Johnson & Johnson Medical, Inc. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
CA2229285A1 (en) 1995-09-21 1997-03-27 Robert Gurny Nanoparticles in photodynamic therapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
IL161881A0 (en) * 2001-11-08 2005-11-20 Upjohn Co N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate

Also Published As

Publication number Publication date
NO20030182D0 (no) 2003-01-14
HU230272B1 (hu) 2015-11-30
NZ523798A (en) 2005-04-29
ES2215924T3 (es) 2004-10-16
CZ2003118A3 (cs) 2003-05-14
AU2001281980B2 (en) 2006-04-06
ZA200210267B (en) 2003-06-12
ATE263557T1 (de) 2004-04-15
PL365380A1 (en) 2005-01-10
EP1303267B1 (de) 2004-04-07
RU2262930C2 (ru) 2005-10-27
DE10034673C1 (de) 2002-04-25
TR200400865T4 (tr) 2004-06-21
CA2416147C (en) 2008-11-18
NO330303B1 (no) 2011-03-28
DK1303267T3 (da) 2004-06-14
AU8198001A (en) 2002-01-30
JP4469131B2 (ja) 2010-05-26
DE50101929D1 (de) 2004-05-13
CA2416147A1 (en) 2002-01-24
PL221283B1 (pl) 2016-03-31
HUP0301089A3 (en) 2006-07-28
WO2002005809A1 (de) 2002-01-24
NO20030182L (no) 2003-01-14
US7951395B2 (en) 2011-05-31
EP1303267A1 (de) 2003-04-23
PT1303267E (pt) 2004-07-30
JP2004503591A (ja) 2004-02-05
US20050013852A1 (en) 2005-01-20
CZ299086B6 (cs) 2008-04-23

Similar Documents

Publication Publication Date Title
CY1106577T1 (el) Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
TR200002179T2 (tr) Kristalin teriparatid.
DK1449917T3 (da) Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
BR0311693A (pt) Sal de formato de o-desmetil-venlafaxina
HUP0301089A2 (hu) Dermális alkalmazási rendszerek aminolevulinsavhoz
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DE69809412D1 (de) Reagenz zur guanidinylierung
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
AU2001281980A1 (en) Dermal application system for amino laevulinic acid
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
DE60136573D1 (de) Gewebefixativzusammensetzung
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
BR0316544A (pt) Compostos calcilìticos
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ATE281522T1 (de) Sentrin-spezifische menschliche protease senp1
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
NO20024679D0 (no) Krystallinsk farmasöytikum
BR0112849A (pt) Processo para a preparação de um composto quiral, e, composto quiral
EA200000946A1 (ru) Кристаллическая форма пароксетина
MXPA04003478A (es) Sintesis de (4-bromofenil)(4-piperidil)metanona-(z)-o-etiloxima y sales.
IT1319660B1 (it) Processo per la preparazione di 1-(1-amminoalchil)ossirani protetti.
BRPI0103418B8 (pt) metodologia para síntese do (+/-) - baclofeno e análogos
SE9704835D0 (sv) New compound